MediPharm Labs Corp.
LABS.TO
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.43M | 8.29M | 8.10M | 7.80M | 6.00M |
| Total Receivables | 4.69M | 5.49M | 5.54M | 5.88M | 5.42M |
| Inventory | 6.02M | 5.73M | 5.69M | 6.69M | 7.25M |
| Prepaid Expenses | 99.10K | 245.80K | 384.80K | 538.90K | 121.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 239.20K | 279.30K | 330.20K | 728.80K | 3.33M |
| Total Current Assets | 18.48M | 20.03M | 20.05M | 21.64M | 22.13M |
|
|
|||||
| Total Current Assets | 18.48M | 20.03M | 20.05M | 21.64M | 22.13M |
| Net Property, Plant & Equipment | 12.40M | 12.83M | 12.88M | 13.56M | 13.09M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 453.20K | 492.30K | 516.90K | 560.20K | 562.80K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | 395.20K | 441.80K |
| Total Assets | 31.33M | 33.36M | 33.45M | 36.15M | 36.22M |
|
|
|||||
| Total Accounts Payable | 3.28M | 3.44M | 3.40M | 3.38M | 3.40M |
| Total Accrued Expenses | 2.06M | 2.72M | 1.65M | 2.08M | 1.51M |
| Short-term Debt | -- | 109.40K | 252.00K | 329.90K | 9.70K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.90K | 37.20K | 51.70K | 60.10K | 55.70K |
| Total Finance Division Other Current Liabilities | 765.60K | 933.50K | 922.50K | 1.10M | 1.15M |
| Total Other Current Liabilities | 765.60K | 933.50K | 922.50K | 1.10M | 1.15M |
| Total Current Liabilities | 6.12M | 7.24M | 6.27M | 6.95M | 6.13M |
|
|
|||||
| Total Current Liabilities | 6.12M | 7.24M | 6.27M | 6.95M | 6.13M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 109.40K | 252.00K | 329.90K | 9.70K |
| Capital Leases | -- | -- | -- | 7.30K | 21.60K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 6.12M | 7.24M | 6.27M | 6.96M | 6.15M |
|
|
|||||
| Common Stock & APIC | 145.01M | 147.25M | 144.76M | 147.84M | 139.99M |
| Retained Earnings | -122.27M | -123.53M | -135.42M | -136.74M | -130.67M |
| Treasury Stock & Other | 2.47M | 2.40M | 17.84M | 18.09M | 20.75M |
| Total Common Equity | 25.21M | 26.12M | 27.18M | 29.19M | 30.08M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 25.21M | 26.12M | 27.18M | 29.19M | 30.08M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 25.21M | 26.12M | 27.18M | 29.19M | 30.08M |
|
|
|||||